DESCRIPTION
RituxiRel (Rituximab) is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen used in the treatment of non-Hodgkin lymphoma (NHL), blood cancer (Chronic lymphocytic leukemia) and rheumatoid arthritis . RituxiRel is a prescription drug.
Manufacturer : Reliance Life Sciences
Reviews
There are no reviews yet.